Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05436587

Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes

Identification of The Novel Mutations and A Comprehensive Analysis of The Phenotype and Genetic Etiology Underlying Unclassifiable Inherited Bone Marrow Failure Syndromes With Bone Fragility Fractures

Status
Recruiting
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Inherited bone marrow failure syndromes (IBMFSs) are a diverse collection of genetic illnesses characterized by various degrees of peripheral cytopenias due to defective single-lineage or multi-lineage hematopoiesis, it can manifest itself at birth or later in life.

Detailed description

Studying the genetic etiology underlying unclassifiable IBMFSs with bone fragility fractures should be useful for clarifying the undiagnosed pathophysiological mechanisms and other accessory factors to improve the diagnosis, follow-up, prognosis, and management of these patients as well as prevent future complications. Moreover, early diagnosis of risk factors of unusual presentations of IBMFSs will be a useful tool for better treatment strategy. In addition, along with typical IBMFSs, novel clinical entities must be included in an overall molecular portrait of IBMF disorders. As a result, comprehensive genetic analysis will be effective in establishing an accurate genetic diagnosis at medical evaluation.

Conditions

Interventions

TypeNameDescription
GENETICThe whole-exome sequencingExome sequencing will be performed at the Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan and will be analyzed at Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Japan.

Timeline

Start date
2022-01-10
Primary completion
2024-01-01
Completion
2028-01-01
First posted
2022-06-29
Last updated
2022-07-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05436587. Inclusion in this directory is not an endorsement.